HK biotech listings gain traction in Q2 with trio of June IPOs
· marian chu
AI Briefing
- • Alebund Pharmaceuticals' IPO in June raised about HK$1.3 billion (US$167 million).
- • Longbio Pharma Co. Ltd.'s IPO in June generated about HK$1.3 billion (US$167 million).
- • Shaanxi Micot Pharmaceutical Technology Co. Ltd.'s IPO in June raised about HK$1.1 billion (US$143 million).
Source Summary
Alebund Pharmaceuticals (Jiangsu) Ltd. was the third Chinese biotech company to debut in Hong Kong this month, with June IPO proceeds from Alebund, Longbio Pharma Co. Ltd. and Shaanxi Micot Pharmaceutical Technology Co. Ltd. totaling about HK$4.7 billion (US$600 million).
Advertisement